Table 2.
Comparison of primary and secondary outcomes between topical amethocaine and saline
| Amethocaine | Saline | P | |
|---|---|---|---|
| Primary outcome | |||
| Corneal defect at 36–48 h | 2/7 (29) | 1/9 (11) | 0.55 |
| Secondary outcomes (“between 48 h and 2 weeks after initial assessment, was there…”) | |||
| Review by another health practitioner | 2/17 (12) | 2/21 (10) | 1 |
| Analgesia used for eye pain | 0/17 | 0/21 | – |
| Visual problems | 3/17 (18) | 1/21 (5) | 0.307 |
| Satisfaction with management | 17/17 (100) | 21/21 (100) | – |
FIGURES IN PARENTHESIS INDICATE PERCENTAGE